Back to search

National and Kapodistrian University of Athens

Απομόνωση εμβρυϊκών κυττάρων από το περιφερικό αίμα της εγκύου: δυνατότητες προγεννητικού ελέγχου

Abstract

dc:description

Isolation of fetal cells from maternal peripheral blood during pregnancy gives today new possibilities to the development of reliable and safe non - invasive prenatal testing, which can be offered to all women, regardless of their age or risk of having a child with chromosomal abnormality. Nucleated Red Blood Cells (NRBCs) are the fetal cells of choice, since they are abundant in first trimester fetal blood, mononuclear and have a full complement of nuclear genes, a distinctive morphology and limited life span. However, their rarity and the lack of specific markers that distinguish them from the maternal ones, hamper their successful isolation. The aim of the present study was the improvement and standardization of techniques for a non – invasive prenatal testing from fetal NRBCs isolated from maternal peripheral blood. 1. Different methods of NRBC enrichment from maternal peripheral blood and two monoclonal antibodies to the transferring receptor, in various combinations, were investigated in order to determine the combination with which the maximum number of fetal NRBCs is retrieved with minimal maternal cell contamination. 2. Use of fetal NRBCs isolated from maternal blood for non - invasive prenatal diagnosis of fetal aneuploidies was evaluated. Twenty ml of peripheral blood were collected from 568 women in the 2nd trimester of pregnancy: 513 women carried chromosomally normal fetuses, 26 had chromosomally abnormal fetuses (trisomy 21: n=18, trisomy 18: n=2, trisomy 13: n=1, mosaic for trisomy 12: n=1, 47,XXX: n=1 and 45,XO: n=3) and 29 samples were obtained from pregnant women, carriers of β-thalassemia trait, known to carry chromosomally normal fetuses. For NRBC enrichment, density gradient centrifugation with Histopaque 1083gr/ml was performed, followed by magnetic activated cell sorting (MACS) using two monoclonal antibodies to the transferrin receptor, conjugated and non - conjugated with magnetic beads, which recognize different epitopes of the receptor. Isolated NRBCs were then stained with May-Grunwald/Giemsa and enumerated using morphological criteria by a light microscope. 190 samples coming from women carrying chromosomally normal fetuses were used for the standardization of the method. Isolation of NRBCs from maternal peripheral blood using a combination of negative and positive selection was compared to positive selection only. The average number of isolated NRBCs after positive selection was higher than that isolated after negative and positive selection (7 against 6) and positive selection was used for the isolation of NRBCs from the remaining samples. Next, the two monoclonal antibodies to the transferring receptor, the commercially available CD71 and 2F6.3 in conjugated and non – conjugated with magnetic beads form were compared. The average number of isolated NRBCs with commercially available CD71 was 6.52 (range 2 – 26) versus 4.04 (range 2 – 14) with non – conjugated 2F6.3. The average number of isolated NRBCs with commercially available CD71 was 7.04 (range 2 – 28) against 5.96 (range 2 – 20) with conjugated 2F6.3. For this reason, commercially available CD71 was used for the isolation of NRBCs from the remaining samples. NRBCs were detected in 475/568 (84%) of the samples tested. Among 416 women with chromosomally normal fetuses, 7 (range 6.52 – 7.5) NRBCs were identified. In 4 cases with normal karyotype an average of 104 (range 77 – 120) NRBCs were isolated, possibly due to the disruption of haemopoiesis in the mother or the random liberation of NRBCs at the time of sampling. In 29 pregnant women carriers of β-thalassemia trait with chromosomally normal fetuses, the mean number of isolated NRBCs was 61 (range 22 – 158). Among 26 women with chromosomally abnormal fetuses, the mean number of isolated NRBCs was 33.5 (range 5 – 113): in 18 cases with a trisomy 21 fetus the mean number was 66 (range 22 – 113), in two pregnancies with a trisomy 18 fetus it was 6 (range 5 – 7) and in one pregnancy with a trisomy 13 fetus it was 37. Eight NRBCs were isolated from the blood of a woman carrying a fetus with mosaic trisomy 12. The average number of isolated NRBCs in 3 pregnancies with a Turner syndrome fetus was 51 (range 43 – 58) and in one woman with a 47,XXX fetus it was 12. FISH was performed in 95 cases where more than 5 NRBCs were identified. In 70 samples from women with chromosomally normal fetuses, FISH was performed in order to determine the fetal sex using X and Y chromosome specific probes and in 25 samples (7 from high risk pregnancies for trisomy 21 and 18 from pregnancies with a trisomy 21 fetus) FISH was performed for the detection of both fetal sex and aneuploidy using X and 21 chromosome specific probes. Hybridization was successful in 70/95 (74%) samples. Fetal sex was correctly determined in 67/70 (96%) cases. In all instances with trisomy 21 the aneuploidy was confirmed and in high risk pregnancies it was excluded. The present study confirms the difficulty of enrichment and FISH analysis on NRBCs isolated from maternal blood due to the lack of specific monoclonal antibodies for their recognition and their apoptotic status. At the same time, it confirms that fetal cells can be isolated from maternal circulation with a magnetic cell sorter and used for the determination of fetal sex and trisomy 21, which is the most common viable fetal aneuploidy. Of significant interest is the increased number of NRBCs in maternal blood in pregnancies with some chromosomal abnormalities which can serve as an additional screening marker for fetal aneuploidies. However, the finding of increased number of NRBCs in women carriers of β-thalassemia trait known to carry chromosomally normal fetuses, as wells as, in almost 1% of pregnancies carrying chromosomally normal embryos could lead to wrong results. Therefore, the above non – invasive technique could be used as an alternative method for identifying the possibility of fetal aneuploidies as long as the anemic status of the mother is taken into consideration.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2011

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Kouvidi, Elisabeth
  • Κουβίδη, Ελισάβετ

Subjects

dc:subject × 13

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/27245

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Kouvidi, Elisabeth; Κουβίδη, Ελισάβετ. Απομόνωση εμβρυϊκών κυττάρων από το περιφερικό αίμα της εγκύου: δυνατότητες προγεννητικού ελέγχου. National and Kapodistrian University of Athens, 2011. http://hdl.handle.net/10442/hedi/27245